$JNJ beats results. Up 4.1% premarket.

Earnings per share $2.30 vs $2.10 est
Revenue growth +3.3% to $20.69 billion
Dividend increases 6.3% to $1.01/share 

Pharmaceutical, medical devices, health sales - all increased. https://t.co/RpV4SmStoO